COAG No. 72068718CA00001 1 TABLE OF CONTENT I- EXECUTIVE SUMMARY .................................................................................................................................................. 6 II- INTRODUCTION ....................................................................................................................................................... 10 III- MAIN ACHIEVEMENTS DURING QUARTER 1 ........................................................................................................... 10 III.1. IR 1: Enhanced coordination among the public, nonprofit, and commercial sectors for reliable supply and distribution of quality health products ........................................................................................................................... 10 III.2. IR2: Strengthened capacity of the GOM to sustainably provide quality health products to the Malagasy people 15 III.3. IR 3: Expanded engagement of the commercial health sector to serve new health product markets, according to health needs and consumer demand ........................................................................................................ 36 III.4. IR 4: Improved sustainability of social marketing to deliver affordable, accessible health products to the Malagasy people ............................................................................................................................................................. 48 III.5. IR5: Increased demand for and use of health products among the Malagasy people ................................... 55 III.6. Cross-Cutting Activities ................................................................................................................................... 59 III.6.1. Gender and Social Inclusion .................................................................................................................... 59 III.6.2. Monitoring, Evaluation, Research, Learning ........................................................................................... 61 IV- KEY CHALLENGES AND SOLUTIONS ......................................................................................................................... 67 V- MAJOR ACTIVITIES PLANNED FOR NEXT Quarter (YEAR 3, JANUARY – MARCH 2021) ........................................... 68 VII- COVID-19 Activities ................................................................................................................................................. 72 VIII- FINANCIAL SUMMARY......................................................................................................................................... 75 ANNEXES ............................................................................................................................................................................. 76 ANNEX A - Performance Monitoring Plan (PMP) ............................................................................................................ 77 ANNEX B - Year 3 Workplan Update ............................................................................................................................... 90 ANNEX C - Environmental Mitigation and Monitoring Report...................................................................................... 100 ANNEX D - SUCCESS STORIES ........................................................................................................................................ 114 ANNEX E - STOCK INVENTORY AS OF DECEMBER 2020 (USAID AND PMI funded) ....................................................... 120 ANNEX F - STOCK STATUS BY END OF DECEMBER 2020 ............................................................................................... 122 ANNEX G - Descriptions of the seven quality dimensions for the RDQA ...................................................................... 125 ANNEX H - ANNEX OF THE COVID-19 Monthly Report October 2020 .......................................................................... 127 ANNEX I - Findings of the exercise for identification of drug shops and pharmacies (Atsimo Andrefana) .................. 135 ANNEX J- Details on malaria commodities redeployments .......................................................................................... 138 2 ACRONYMS A2F Access to Finance JSI John Snow Int. ABM Accès Banque Madagascar LLIN Long Lasting Insecticide-treated Net ACCESS Accessible Continuum of Care and LMIS Logistic Management Information Essential Services Sustained System ACT Artemisinin-based Combination MCH Maternal and Child Health Therapy MNCH Maternal Newborn and Child Health ADDO Accredited Drug-Dispensing Outlet MDA Market Development Authority AGPM Grossistes Pharmaceutiques de M&E Monitoring and Evaluation Madagascar MERL Monitoring Evaluation Research and AMP Alliance for Malaria Prevention Learning ARTMIS Automated Requisition Tracking MOPH Ministry of Public Health -PSM Management Information System- MOU Memorandum of Understandings Procurement and Supply Management MSM Marie Stopes de Madagascar cCD Community-based Continuous MYS Ministry of Youth and Sport Distribution NCC National Coordinating Council CGL Comité de Gestion Logistique NGO Non-Governmental Organization CHU Centre Hospitalier Universitaire NMCP National Malaria Control Program CHV Community Health Volunteers (PNLP) CMS Credit Management System OMS Organisation Mondiale de la CNFM Conseil National des Femmes de Santé/Word Health Organization Madagascar ONP Ordre National des Pharmaciens de COP Chief of Party Madagascar CHRR Centre Hospitalier de Référence ORS Oral Rehydratation Solution Régional PA Point d’Approvisionnement CSR Corporate Social Responsibility PAIS Plan d’Action d’Intégration des Intrants CSB Centre de Santé de Base de santé CNE National Registration Committee PARC Point d’Approvisionnement Relais (Commission Nationale de Communautaire l’Enregistrement PARN Projet d'Amélioration des Résultats CoAg Cooperative Agreement Nutritionnels COGS Cost of Good Sold PDPN Plan Directeur Pharmaceutique CYP Couple Year Protection Nationale DAMM Direction de l’Agence de Médicaments PDSS Plan de Développement du Secteur de Madagascar Santé DCOP Deputy Chief of Party PMI President’s Malaria Initiative DEPSI Direction des Etudes de la Planification PMP Performance Monitoring Plan et du Système d’Information PNLIS Programme National de Lutte contre l’ DFC United States International IST/SIDA Development Finance Corporation PNLT Programme National de Lutte contre la DGFS Direction Générale de Fourniture des Tuberculose Soins PPE Personal Protection Equipment DGMP Direction Générale de la Médecine PPR Performance Plan and Report Préventive PPN Politique Pharmaceutique Nationale DGR Direction Géneral des Ressources PPS Probability Proportional to Population DHIS-2 District Health Information System - 2 Size 3 DLMT Direction de Lutte contre les Maladies PSHP Private Sector Humanitarian Platform Transmissibles PSI/M Population Services DLMNT Direction de Lutte contre les Maladies International/Madagascar Non Transmissible Pha-G-Dis Pharmacie de Gros de District DMPA Depot-Medroxyprogesterone Acetate Pha-Ge-Com Pharmacie à Gestion 5Intra Musculaire or Sous Cutané) Communautaire DPAL Direction PALU- PSI RBM Roll Back Malaria DPLMT Direction de la Pharmacie, des RH Reproductive Health Laboratoires et de la Médecine RDT Rapid Diagnostic Test Traditionnelle RDQA Routine Data Quality Assessment DPS Direction de la Promotion de la Santé RLA Regional Logistic Advisor DRSP Direction Régionale de la Santé SAF/FJKM Sampan’ Asa Fampandrosoana/FJKM Publique SALAMA Centrale d’Achats de Médicaments DSFa Direction de la Santé Familiale Essentiels et de Matériel Médical de DSS Division Santé Scolaire Madagascar DSSB Direction des Services de Santé de SALFA Sampan’ Asa Loterana ho an’ny Base FAhasalamana EDM Electricité De Madagascar SBCC Social and Behavior Change EFOI Entreprendre au Féminin Océan Indien Communication EMAD Equipe MAnagement du District SCM Supply Chain Management /District Management Team SDSP Service de District de Santé Publique/ EMAR Equipe MAnagement de la Région/ District Public Health Service Regional Management Team SG Secretariat Général SHOPS Plus Sustaining Health Outcomes in the EMMP Environmental Mitigation Monitoring Private Sector Plus Plan SLRC Service de la Législation, de la EUV End Users Verification Réglementation et du Contentieux FANOME Financement pour SMSR Service of Maternité Sans Risque l’Approvisionnement Non-stop en SP Sulfadoxine Pyriméthamine Médicaments SPARS Supervision Performance Assessment, FEFO First Expiry – First Out and Recognition Strategy FISA FIanakaviana SAmbatra SPD Superviseurs de Point de Distribution FP Family Planning SRD Superviseur Régional de Distribution GAS Gestion des Approvisionnements et TA Technicien Accompagnateur des Stocks TCA Total Cost Analysis GAVI Global Alliance for Vaccination and TFP Technical and Financial Partners Immunization TMA Total Market Approach GBV Gender Based Violence TMI Total Market Initiative GESI Gender Equality and Social Inclusion ToT Training of Trainers GF Global Fund TWG Technical Working Group GHSC-PSM Global Health Supply Chain – UCP Unité de coordination des Projets Procurement and Supply Management UHC Universal Health Coverage GOM Government of Madagascar UNFPA United Nations Population Fund HPN Health Population and Nutrition UNICEF United Nations of International HRD Health Regional Director Children's Emergency Fund UTGL Unité Technique